Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo.
about
Clinical significance of T cell metabolic reprogramming in cancerTargeting metabolism in breast cancer: How far we can go?Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsetsVibrational Imaging of Glucose Uptake Activity in Live Cells and Tissues by Stimulated Raman ScatteringA molecular switch on an arrestin-like protein relays glucose signaling to transporter endocytosis.Chemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in VivoSrc Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure.The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector functionA comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs.Protein crystallography and fragment-based drug design.Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer questionAttacking the supply wagons to starve cancer cells to death.Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma.Functional analyse of GLUT1 and GLUT12 in glucose uptake in goat mammary gland epithelial cells.Caudal fourth ventricular administration of the AMPK activator 5-aminoimidazole-4-carboxamide-riboside regulates glucose and counterregulatory hormone profiles, dorsal vagal complex metabolosensory neuron function, and hypothalamic Fos expression.Non-invasive, simultaneous quantification of vascular oxygenation and glucose uptake in tissue.Delivery rate affects uptake of a fluorescent glucose analog in murine metastatic breast cancer.IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.Glycolysis is governed by growth regime and simple enzyme regulation in adherent MDCK cells.Favourable response to ketogenic dietary therapies: undiagnosed glucose 1 transporter deficiency syndrome is only one factor.Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHAThe Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas.Gene regulation of UDP-galactose synthesis and transport: potential rate-limiting processes in initiation of milk production in humans.GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degenerationMetabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients.Lrp5 Has a Wnt-Independent Role in Glucose Uptake and Growth for Mammary Epithelial CellsNutrient transporters: the Achilles' heel of anabolism.Genetic mouse models to study blood-brain barrier development and functionImpact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancerProgressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis.Glucose conjugation for the specific targeting and treatment of cancer.Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancerZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose.The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.Defining the molecular basis of tumor metabolism: a continuing challenge since Warburg's discovery.Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells.A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1α activation, tumorigenesis and metastasis.
P2860
Q26741974-C0C84432-2353-45E2-8614-A276C89787EBQ26767022-559BB4F5-90CD-4EEE-A47F-0D98FC544DB4Q27334435-0B0D969E-5FC1-4956-9445-31A98A5A50E6Q27339639-6A4444ED-88E0-433F-A949-3B9833A758EFQ27939281-2711A7E5-64A4-4C79-AC0E-E9DE073B7729Q28828412-2A96DE83-9538-4D9F-A8CD-B5BC0DB81B3AQ30679405-C166E5AD-BC3E-436A-8189-9A22B3A1F964Q33680469-64FCF653-26BC-496D-955C-564E0C46F013Q33838591-2A69215F-3292-4231-A0E3-F0F2873B7612Q34045234-DF0DD01E-A309-45C1-B328-BFA731D3BD94Q34353117-8C17413A-126C-4C6C-8162-409F270BF82AQ34459681-6D07F5F3-5B6E-447D-BA26-8B7BDD43E931Q34516773-56239C5B-AAAC-4415-B18F-48C1C8151353Q34702270-8A85FEF3-C6B8-4C37-AA79-F5C9492D83A9Q34749930-8276DEDD-0E2E-45A9-A3B4-E31ADD334F56Q34793704-E30905E9-6804-4DC9-AD06-C9481A0F9800Q35031920-0BE253DC-ECF0-4B95-B7FC-7A44F45C4583Q35034709-7726C005-9EDD-4641-8B52-261A33DA16EAQ35235735-B7313262-CF6F-4AE1-AB36-39378B6A1D49Q35347611-9BDD96AA-01D1-47E3-8094-519CF60CE2EFQ35614913-C9A6B7B5-1492-42D2-831E-657F11C4952EQ35674921-39D5B732-4655-4C30-91BC-EC94C73B8B1CQ36092014-2DA78CAC-5FED-4046-83AA-0F8B205F6059Q36176001-C12BCE73-81CF-4398-9548-C5AB07010635Q36526013-7B9723C5-01DF-4B3D-8BD5-FC90C6114287Q36657326-0940368E-6954-4374-B05E-DBF42684F30BQ36736195-7FA317F7-4C94-4DF7-9B85-1EA02E019DD3Q36741646-52072F80-C817-4742-9DBE-E63D7568E781Q36909576-DD1ABA90-C765-48B5-BAC9-E0B0452610CBQ36935015-A6DEFC51-F085-4AC2-925B-4A1F7B2A196AQ37062935-5A51733D-80FD-4F40-BAFB-03E342B12D62Q37200539-A8309F47-CDB1-4FAC-B47F-1326F6E29BE7Q37277241-01BB4EDA-BF02-4746-A57F-20AE86246D2FQ37412531-89BC1D71-D1CA-4A99-A369-FF9D0414A5F9Q37517621-E9F4E437-1742-416C-9A12-8A5F11EAF345Q37575221-BF6DAA65-A86E-4D2B-BADD-25E04328BD50Q37738585-86C6FF2A-337C-4879-B6DC-F3060DFEF1C5Q37969537-3A44E6E6-8551-420A-9E33-BA0DC688AAE1Q38714538-020BEA1B-FB07-43BD-83F2-8D3290EA3CC9Q38727581-8A32E737-527D-4663-AB96-8E0C4A95581D
P2860
Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Modulation of glucose transpor ...... l growth in vitro and in vivo.
@ast
Modulation of glucose transpor ...... l growth in vitro and in vivo.
@en
type
label
Modulation of glucose transpor ...... l growth in vitro and in vivo.
@ast
Modulation of glucose transpor ...... l growth in vitro and in vivo.
@en
prefLabel
Modulation of glucose transpor ...... l growth in vitro and in vivo.
@ast
Modulation of glucose transpor ...... l growth in vitro and in vivo.
@en
P2093
P2860
P1433
P1476
Modulation of glucose transpor ...... ll growth in vitro and in vivo
@en
P2093
Andrew S Lewis
Christian D Young
Marisa D Ruehle
Matthew R Jackman
Michael C Rudolph
Olesya Ilkun
Renata Pereira
Steven M Anderson
P2860
P304
P356
10.1371/JOURNAL.PONE.0023205
P407
P50
P577
2011-08-03T00:00:00Z